← Back to Clinical Trials
Recruiting NCT06765226
Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps
◆ AI Clinical Summary
Plain-language summary for patients
Trial Parameters
Condition Heart Failure
Sponsor Abiomed Inc.
Study Type OBSERVATIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-09-21
Completion 2030-07-31
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Analysis of cell and protein deposits on the Impella Heart Pump.
Eligibility Criteria
Inclusion Criteria: * Patients with Impella 5.5 therapy and duration of support for ≥ 25 days OR Patients with Impella CP therapy and duration of support for \> 4 days Exclusion Criteria: * Age \< 18 years
Related Trials
NCT07458074
MIRAMACS, Multicenter Italian Study on RAdial Mechanically Assisted Circulatory Support
View Trial →
NCT06765226
Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps
View Trial →
NCT06008197
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospital
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology